These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 9013494)

  • 21. TNF ligands and receptors in autoimmunity: an update.
    Mackay F; Kalled SL
    Curr Opin Immunol; 2002 Dec; 14(6):783-90. PubMed ID: 12413530
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Another cell death induction system: TNF-alpha acts as a ligand for Fas in vaginal cells.
    Suzuki A; Tsutomi Y; Shimizu M; Matsuzawa A
    Cell Death Differ; 1999 Jul; 6(7):638-43. PubMed ID: 10453074
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of tumour necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) receptors and sensitivity to TRAIL-induced apoptosis in primary B-cell acute lymphoblastic leukaemia cells.
    Clodi K; Wimmer D; Li Y; Goodwin R; Jaeger U; Mann G; Gadner H; Younes A
    Br J Haematol; 2000 Nov; 111(2):580-6. PubMed ID: 11122106
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of Tumor Necrosis Factor-alpha (TNF-α) in the pathogenesis of systemic lupus erythematosus.
    Postal M; Appenzeller S
    Cytokine; 2011 Dec; 56(3):537-43. PubMed ID: 21907587
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunology. Lymphocyte survival--ignorance is BLys.
    Laâbi Y; Strasser A
    Science; 2000 Aug; 289(5481):883-4. PubMed ID: 10960320
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [TNF family (TNF alpha, beta, FasL, CD40L)].
    Manago S; Yonehara S
    Nihon Rinsho; 2005 Apr; 63 Suppl 4():202-6. PubMed ID: 15861657
    [No Abstract]   [Full Text] [Related]  

  • 27. Human astrocytes are resistant to Fas ligand and tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis.
    Song JH; Bellail A; Tse MC; Yong VW; Hao C
    J Neurosci; 2006 Mar; 26(12):3299-308. PubMed ID: 16554480
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The apoptotic ligands TRAIL, TWEAK, and Fas ligand mediate monocyte death induced by autologous lupus T cells.
    Kaplan MJ; Lewis EE; Shelden EA; Somers E; Pavlic R; McCune WJ; Richardson BC
    J Immunol; 2002 Nov; 169(10):6020-9. PubMed ID: 12421989
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The TNF-TNF receptor system.
    Hehlgans T; Männel DN
    Biol Chem; 2002 Oct; 383(10):1581-5. PubMed ID: 12452434
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The three HveA receptor ligands, gD, LT-alpha and LIGHT bind to distinct sites on HveA.
    Sarrias MR; Whitbeck JC; Rooney I; Ware CF; Eisenberg RJ; Cohen GH; Lambris JD
    Mol Immunol; 2000 Aug; 37(11):665-73. PubMed ID: 11164894
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Emerging applications of the tumor necrosis factor family of ligands and receptors in cancer therapy.
    Younes A; Kadin ME
    J Clin Oncol; 2003 Sep; 21(18):3526-34. PubMed ID: 12972530
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Functions of newly identified members of the tumor necrosis factor receptor/ligand superfamilies in lymphocytes.
    Kwon B; Youn BS; Kwon BS
    Curr Opin Immunol; 1999 Jun; 11(3):340-5. PubMed ID: 10465590
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The lymphotoxin pathway: beyond lymph node development.
    McCarthy DD; Summers-Deluca L; Vu F; Chiu S; Gao Y; Gommerman JL
    Immunol Res; 2006; 35(1-2):41-54. PubMed ID: 17003508
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Apoptotic molecules in pancreatic carcinoma cell lines.
    Ringel B; Ibrahim SM; Köhler H; Ringel J; Koczan D; Liebe S; Löhr M; Thiesen HJ
    Ann N Y Acad Sci; 1999 Jun; 880():175-8. PubMed ID: 10415862
    [No Abstract]   [Full Text] [Related]  

  • 35. Expression of osteoprotegerin, receptor activator of NF-kappaB ligand (osteoprotegerin ligand) and related proinflammatory cytokines during fracture healing.
    Kon T; Cho TJ; Aizawa T; Yamazaki M; Nooh N; Graves D; Gerstenfeld LC; Einhorn TA
    J Bone Miner Res; 2001 Jun; 16(6):1004-14. PubMed ID: 11393777
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A role for tumour necrosis factor-alpha, Fas and Fas-Ligand in marrow failure associated with myelodysplastic syndrome.
    Gersuk GM; Beckham C; Loken MR; Kiener P; Anderson JE; Farrand A; Troutt AB; Ledbetter JA; Deeg HJ
    Br J Haematol; 1998 Oct; 103(1):176-88. PubMed ID: 9792306
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of apoptosis-inducing receptors of the tumor necrosis factor family in thyroid cancer.
    Mitsiades CS; Poulaki V; Mitsiades N
    J Endocrinol; 2003 Aug; 178(2):205-16. PubMed ID: 12904168
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Abnormal Fas and Fas ligand expression of lymphocytes in patients with SLE].
    Suzuki N; Sakane T
    Nihon Rinsho; 1996 Jul; 54(7):1955-9. PubMed ID: 8741694
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Beyond TNF: TNF superfamily cytokines as targets for the treatment of rheumatic diseases.
    Croft M; Siegel RM
    Nat Rev Rheumatol; 2017 Apr; 13(4):217-233. PubMed ID: 28275260
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mature follicular dendritic cell networks depend on expression of lymphotoxin beta receptor by radioresistant stromal cells and of lymphotoxin beta and tumor necrosis factor by B cells.
    Endres R; Alimzhanov MB; Plitz T; Fütterer A; Kosco-Vilbois MH; Nedospasov SA; Rajewsky K; Pfeffer K
    J Exp Med; 1999 Jan; 189(1):159-68. PubMed ID: 9874572
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.